KRAS Inhibitors in Pancreas Cancer: Facts and Hopes about the Immunotherapy We Have All Been Waiting for.

Stanger BZ, Vonderheide RH

Open source

DOI
10.1158/1078-0432.ccr-25-0821
Published
2026 Apr 15
Container
Clinical cancer research : an official journal of the American Association for Cancer Research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-25-0821,
  title = {KRAS Inhibitors in Pancreas Cancer: Facts and Hopes about the Immunotherapy We Have All Been Waiting for.},
  author = {Stanger BZ and Vonderheide RH},
  year = {2026},
  journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
  doi = {10.1158/1078-0432.ccr-25-0821},
  url = {https://doi.org/10.1158/1078-0432.ccr-25-0821}
}

RIS

TY  - JOUR
TI  - KRAS Inhibitors in Pancreas Cancer: Facts and Hopes about the Immunotherapy We Have All Been Waiting for.
AU  - Stanger BZ
AU  - Vonderheide RH
PY  - 2026
JO  - Clinical cancer research : an official journal of the American Association for Cancer Research
DO  - 10.1158/1078-0432.ccr-25-0821
UR  - https://doi.org/10.1158/1078-0432.ccr-25-0821
ER  - 

APA

BZ, S., & RH, V. (2026). KRAS Inhibitors in Pancreas Cancer: Facts and Hopes about the Immunotherapy We Have All Been Waiting for.. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.ccr-25-0821

Source records